Innovo Therapeutics
Seoul, Seoul-t'ukpyolsi, South Korea
About Innovo Therapeutics
Innovo Therapeutics creates an artificial intelligence drug research and development platform to find new drugs. DeepZema is the company's proprietary AI-augmented drug discovery platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Jan 2021)
- Website: innovothera.co.kr
- Phone: +82(2)-6956-8680
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/innovo-therapeutics-2501213 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.